Showing results (471-480 of 672) with videos related to
Sort By:
Pageof 68
Biological Psychiatry|February 15, 1995
Primary structure of the serotonin transporter in unipolar depression and bipolar disorderK P Lesch, J Gross, E Franzek, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 29, 2000
Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depressionK P Lesch, S Jatzke, J Meyer, et al.International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|January 13, 2001
Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brainsN Durany, T Michel, J Kurt, et al.Journal of Chemical Neuroanatomy|February 24, 2001
Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?G Münch, H J Lüth, A Wong, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cellsU Wüllner, M Weller, J Kornhuber, et al.Ultrasound in Medicine & Biology|August 26, 1999
Iron accumulation in the substantia nigra in rats visualized by ultrasoundD Berg, C Grote, W D Rausch, et al.Journal of Neural Transmission. General Section|January 1, 1995
Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studiesJ Kornhuber, C G Parsons, S Hartmann, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 30, 1998
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stressC Loske, A Neumann, A M Cunningham, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|April 11, 2006
Evidence for specific phases in the development of human neuromelaninG M Halliday, H Fedorow, C H Rickert, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 30, 1998
Acetylcholine in human CSF: methodological considerations and levels in dementia of Alzheimer typeL Frölich, A Dirr, M E Götz, et al.Pageof 68